Needham Reiterates Buy on Cardlytics, Maintains $10 Price Target
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Kyle Peterson has reiterated a Buy rating on Cardlytics (NASDAQ:CDLX) and maintained a $10 price target.
June 06, 2023 | 10:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Kyle Peterson reiterates a Buy rating on Cardlytics (NASDAQ:CDLX) and maintains a $10 price target.
The news directly mentions Cardlytics (NASDAQ:CDLX) and the Buy rating reiterated by Needham analyst Kyle Peterson. This positive rating and maintained price target of $10 could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100